Intrinsic Edge Capital Management LLC Natera, Inc. Transaction History

Intrinsic Edge Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$28.13 - $44.54 $1.41 Million - $2.23 Million	-50,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $1.52 Million - $4.57 Million	50,000 New	50,000 $2.03 Million
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $3.49 Million - $4.81 Million	-40,445 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $6.38 Million - $8.05 Million	-63,736 Reduced 61.18%	40,445 $4.51 Million
Q2 2021 Aug 16, 2021	BUY	$86.05 - $119.72 $8.96 Million - $12.5 Million	104,181 New	104,181 $11.8 Million
Q2 2020 Aug 14, 2020	SELL	$26.36 - $49.86 $4.09 Million - $7.73 Million	-155,094 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$17.27 - $40.17 $720,331 - $1.68 Million	-41,710 Reduced 21.19%	155,094 $4.63 Million
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $6.32 Million - $7.95 Million	196,804 New	196,804 $6.63 Million

527

118M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $15.7B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Intrinsic Edge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Intrinsic Edge Capital Management LLC with notifications on news.